What is a stock summary page? Click here for an overview.
Business Description
NextGen Biomed Ltd
ISIN : IL0010839301
Description
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.29 | |||||
| Equity-to-Asset | -4.07 | |||||
| Debt-to-Equity | -0.1 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -14 | |||||
| 3-Year EPS without NRI Growth Rate | -14.8 | |||||
| 3-Year FCF Growth Rate | 18.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.63 | |||||
| 9-Day RSI | 68.21 | |||||
| 14-Day RSI | 62.07 | |||||
| 3-1 Month Momentum % | -19.38 | |||||
| 6-1 Month Momentum % | -21.05 | |||||
| 12-1 Month Momentum % | -48.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.4 | |||||
| Shareholder Yield % | -45.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -885.16 | |||||
| ROIC % | -413.25 | |||||
| 3-Year ROIIC % | 22.04 | |||||
| ROC (Joel Greenblatt) % | -2091.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.98 | |||||
| EV-to-EBITDA | -1 | |||||
| EV-to-FCF | -2.21 | |||||
| Earnings Yield (Greenblatt) % | -101.89 | |||||
| FCF Yield % | -45.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NextGen Biomed Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | |||
| EPS (TTM) (₪) | -0.581 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.15 | ||
| 3-Year Sortino Ratio | -1.5 | ||
| Volatility % | 28.81 | ||
| 14-Day RSI | 62.07 | ||
| 14-Day ATR (₪) | 0.047705 | ||
| 20-Day SMA (₪) | 0.6111 | ||
| 12-1 Month Momentum % | -48.61 | ||
| 52-Week Range (₪) | 0.528 - 1.25 | ||
| Shares Outstanding (Mil) | 7.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NextGen Biomed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NextGen Biomed Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
NextGen Biomed Ltd Frequently Asked Questions
What is NextGen Biomed Ltd(XTAE:NXGN)'s stock price today?
The current price of XTAE:NXGN is ₪0.65. The 52 week high of XTAE:NXGN is ₪1.25 and 52 week low is ₪0.53.
When is next earnings date of NextGen Biomed Ltd(XTAE:NXGN)?
The next earnings date of NextGen Biomed Ltd(XTAE:NXGN) is .
Does NextGen Biomed Ltd(XTAE:NXGN) pay dividends? If so, how much?
NextGen Biomed Ltd(XTAE:NXGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers